Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed)
This grant supports research on new therapies and testing methods for neurological disorders, especially epilepsy, including treatment, prevention, and human-focused testing strategies.
Funder: National Institutes of Health (NIH)
Due Dates: February 20, 2026 (Forecasted)
Funding Amounts: $3,500,000–$4,000,000 per award | 1 expected award | Total program funding: $6,200,000
Summary: Supports research into novel therapeutic interventions and testing strategies for neurological disorders, with a focus on epilepsy treatment, modification, and prevention.
Key Information: Forecasted opportunity; details may change—check for updates.
Description
This upcoming funding opportunity from the National Institute of Neurological Disorders and Stroke (NINDS) is intended to support research on innovative therapeutic interventions and testing strategies for neurological disorders, with a particular emphasis on epilepsy. The program encourages proposals that explore a variety of intervention modalities and human-focused testing approaches. Applications from investigators with expertise in preclinical therapy testing and model development are especially welcomed. The ultimate goal is to advance methods for treating, modifying, or preventing epilepsy and related neurological conditions.
